The macrophage-induced increase in tumour cell EGFR activity can be reduced significantly by an iNOS inhibitor, suggesting a novel mechanism of how proximity to macrophages in the microenvironment can regulate tumour cell signalling and hence give rise to the observed intratumor heterogeneity in EGFR signalling activity. This evidence concerns the gene EGFR and neoplasm.